PUBLICATIONS

Published Works & Scientific Contributions.

Awards

2025 Business women of the year finalist. Border Kei Region

2024 Winner of Woman of South Africa Imbokodo awards in the following categories: Woman in Medicine, Woman in STEM, Woman in healthcare and wellness, and Woman in education and training

2024 First Prize winner for Medical Research in Africa at (SAMA) South African Medical Association Conference

2023 Overall winner of the Fabulous Woman Awards in healthcare 2023

2023 Olympus International Award in Medical and Research category

2023 Maverick Business Award winner

2023 Wonder woman award healthcare winner

2022 Global Governance awards healthcare category in Nigeria and awarded: “Africa’s leading medical professional of the year 2022” for her work in medical cannabis

2022 Woman of Stature Winner in the healthcare category and represented South Africa in Dubai

2022 Woman of Wonder Award Recipient 2022 Medical and Research

2022 Influential Woman of the Year winner 2022 Medical Science and Healthcare

2022 Finalist for the Gender main streaming awards in healthcare and positive role model.

2022 Won the Mrs Tourism Global Humanity Ambassador in Thailand

2021 Won the Mrs Tourism Universe South Africa title

2019 Merit Award for Public Health Medicine

2016 AOSIS publishing. A peer reviewer for Open Access journal

2012 Selected as 1 of 10 internationally for PHD in Business Leadership

2011 Cum Laude for Labour Relations Management

2010 Merit award for MBA

2004 Cum Laude award for degree in Biomedical Science

2002 Award for Distinction and achieving the highest in the country for HPCSA Board Exam in Clinical Pathology

2000 Cum Laude and Vice Chancellors award for Biomedical Science

1998 Award for A Aggregate for Matric exams

Publications

Gallow, S., Ross, A., Pillay., & Mkhize, B. 2025. Cannabinoids and chemotherapy in prostate Cancer: A scoping review of pain relief and quality of life. Next Research Journal. ISSN 3050 Volume 2 (3) https://doi.org/10.1016/j.nexres.2025.100506.

Broeslid, S and Gallow, S. 2025. Bridging the Gap: Integrating the Endocannabinoid System into Medical Education https://www.researchgate.net/publication/391698869_Bridging_the_Gap_Integrating_the_Endocannabinoid_System_into_Medical_Education

Gallow, S., Rena, R., & Kharub, M. (2025). Developing a tailored retention model for healthcare professionals: A mixed-methods study in South African pathology laboratories. International Journal of Healthcare Management, 1–17. https://doi.org/10.1080/20479700.2025.2518065

Ramjawan, S., Gallow, S., Baker, M., Bihiha, C. et al. 2023. Watering the Seed-stories of personal Growth. Chapter 8: Woman in the Mirror. ISBN 978-0-6397-9624-6. Elevate Business solutions

Quarshie, G. Agu, L. Abogye, R. Gallow, S. Wilkinson, S. Mohamed, A and Gasper, T. 2022. African Women Who Inspire. ISBN 9-798356-446054

Orlando, B. Gallow, S. 2021. Corporate Social Responsibility: Chapter one: Human Resources Remain Our Biggest Assets. ISBN 978-1-83880-939-3. Intech Open Limited UK.

Gallow, S. Nel, J. & Williams, A. 2020. A conceptual model to retain non-professionals in a private healthcare setting. SA Journal of Human Resource Management | Vol 18 | a1281 | DOI: https://doi.org/10.4102/sajhrm.v18i0.1281 |

Gallow, S. 2019. Retention Recipe: A Guide for Healthcare Professionals. ISBN 13: 978-3-639-51411-7. http://www.scholars-press.com

Gallow, S. 2019. HIV: An African Intervention Strategy. ISBN 13: 978-613-8-91525-6. http://www.scholars-press.com

Gallow, S. 2020. Breast cancer and cannabinoids. Open Access. https://www.researchgate.net/publication/335260048_Breast_Cancer_and_Cannabinoids_Evidence_based_confidence_level_and_Therapeutic_potential

Reddy, S. 2010. Investigation of high turnover in a private pathology lab in the Eastern Cape. UNISA library. www.unisa.ac.za

Reddy, S. 2009. Liver Cirrhosis. Medmall Article. www.medmall.co.za

Reddy, S. 2009. A Further Insight into Iron Deficiency Anemia, Medmall Article. www.medmall.co.za

Reddy, S. 2009. Ethics in Medical Technology, Medmall. www.medmall.co.za

Reddy, S. 2015. UNISA. Development of a retention model for scarce skilled employees in the health sector

Gallow, S. 2018. University of Roehampton UK. The effect of the Eastern Cape Department of Health’s HIV awareness campaigns at rural Mdtansane schools and villages

Publications in progress

Gallow, S., Ross, A., Pillay., & Mkhize, B. 2024. Comprehensive evaluation of the impact of cannabinoids on prostate cancer: Integrating PSA, PET/CT Scans and Patient related outcomes. Medical cannabis and cannabinoids journal

Gallow, S., Ross, A., Pillay., & Mkhize, B. 2024. Exploring the impact of cannabinoids on PSA, PET/CT Scans in prostate cancer: A Comprehensive systematic literature review. Frontiers Journal of Oncology Reviews

Gallow, S., Hurley, R., Jamooldeen & Katerere, D. 2024. Assessing the efficacy of medical cannabis as a

Substitution therapy for opioids in chronic pain management: A comprehensive investigation. Ethno Pharmacology

Frontiers Journal

Broselid, S and Gallow, S. The Endocannabinoidome: Key to Physiological Regulation and Therapeutic innovation  – Advancing  Medical Education and Personalized Care. Advanced Gut and Microbiome Research

Presentations and Conferences

73rd International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA), jointly with Italian Society of Phytochemistry Naples Italy. Assessing the Efficacy of Medical Cannabis as a Substitution Therapy for Opioids in Chronic Pain Management: A Comprehensive Investigation” (ID: 95

73rd International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA), jointly with Italian Society of Phytochemistry Naples Italy. “Comprehensive Evaluation of the ‘Impact of Cannabinoids’ on Prostate Cancer: Integrating PSA, PET/CT Scans, and Patient-Related Outcomes”

CannMed 2025. Puerto Rico. Comprehensive evaluation of the impact of cannabinoids on prostate cancer. Integrating PSA, PET/CT

United in Compassion Medical Cannabis Conference, Australia. A comprehensive review of medical cannabinoids and prostate cancer

Philippines Rotary Club. Removing the stigma of medical cannabis

Poster presentation. University of Maryland Baltimore, USA. Can cannabinoids be a possible treatment for prostate cancer?

Key note speaker. UCIMED Medical School Costa Rica. Medical cannabinoids removing the stigma

Key note speaker. IMSK. Kenya Removing the Stigma of Medical Cannabis.

Key note speaker. Therapeutic benefits of minor cannabinoids. Greece.

Germany IACM conference. Presented alongside Dr Ethan Russo, Dr Bonnie Goldstein, Dr Franjo Grotenhem and Dr Iain Mcgregor. Medical cannabis trends in South Africa

Research abstract presentation. South African Medical Association (SAMA) Conference. Sandton. Could

          Cannabinoids be a possible treatment for medical cannabis?

Key note speaker at Hemp and Cannabis Conference in Bangkok Thailand. Clinical Applications of medical cannabis

Panel discussion with Tshwane University of Technology. Prof Katerere, Dr Gallow, Dr Shavhani.. Cannabis Expo KZN July 2023. Medical cannabinoids into products

Cannabis Expo KZN. Key note speaker. Medical cannabis: A true life event.

Cannabis Europa UK. Medical Cannabis Research in South Africa

International Cannabis Conference (ICBC). Berlin Germany. Sponsored by EU to represent SA

Panel discussions Nigeria on Global Governance and Africa.

2022 Presented at the Cannabis Expo Sandton. Key note speaker: Medical cannabis research in South Africa replacing opioids with medical cannabis for chronic pain

2022 Panel discussion at the Cannabis Expo Sandton: Medical cannabis and women’s health

Woman’s day event. Plettenberg Bay Western Cape Panel discussion: Cannabis and women’s health

Womans day event: Key note speaker. Women in Medical cannabis

Dr Shiksha Gallow presents the medical segment every second week on CannaSphere which is streamed on DSTB Cape TV. Medical cannabis in SA

Dubai. Hadarat Global woman’s summit, Business negotiations beyond borders. Participated in panel discussion: Using neuroscience to accelerate business

Presented at the SCC International meeting: USA: Medical Cannabis in South Africa: The Future for a global healing awakening 2022

Presented at the Cannabis Expo Cape Town: Panel discussions: Cannabis and Covid-19. Science or Hype 2022

Presented at the Cannabis Expo Cape Town: Panel discussions: Medical cannabis- Learning from the global market 2022

Presented at the Cannabis Expo Cape Town: Panel discussions: Women in Cannabis: Change makers and leaders

Presented at South African Medical Association (SAMA): East London Life hospital: Medical cannabis and the evidence to treat patients

Presented at the Cannabis Expo Cape Town: Key Note: Medical cannabis research and anecdotal evidence

Presented at the Cannabis Expo (Sandton): Key Note speaker 2021. Medical Cannabis research in South Africa

Presented at Toronto Canada for government conference: Medical cannabis in South Africa: Opportunities for the global market 2019

Presented at Cannabis Conference in East London for government conference: Healing with cannabinoids: The Evidence 2019

Presented at CannaTech: Medical Cannabis: What’s the Evidence: Medical Cannabis Conference November 2019

Presented at WESGRO:  Medical cannabis: a Brief Push to the Past at Congress 2018

Presented at Cannabis Expo: Medical Cannabis: The Evidence 2018

Presented in Leipzig Germany: Key Note speaker representing Wits health consortium: The H3Africa biorepository project lined to the HIV vaccine trial 2013

Presented in Tanzania at the Medical Conference: Key Note speaker: The H3 Africa Biorepository global project started at Wits Health Consortium

Presented a paper on: “Laboratory Management: Back to the Future” at PathTech Congress in 2009: Sun City

Presented a paper on “Laboratory Automation in the Eastern Cape” at Biomeriux Congress in 2011: Pretoria

Research Support

  1.  IAVI – USAID # GPO-A-00-06-00006-00    PI: Jill Gilmour    2005 – 2013

The International AIDS Vaccine Initiative (IAVI) is a non-profit public-private product development partnership founded in 1996 whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI’s work focuses on four areas: accelerating scientific progress; mobilizing public support through issue advocacy and education; encouraging industrial involvement in AIDS vaccine development; and working to assure global access to a vaccine.

IAVI is a global organization and employees are located in the US (New York head office and San Francisco office), Europe (Amsterdam office), Africa (Kenya office in Nairobi and South Africa office in Johannesburg) and India (New Delhi office).

Role: Laboratory Operations and Management, WHC CLS Chief Operations Officer: Dr Shiksha Gallow

  1. FACTS – USAID # IND # 73, 382    PI: Helen Rees    2010 – 2015                                              

A Phase III, Multi-Centre, Randomized Controlled Trial to Assess the Safety and Effectiveness of the       Vaginal Microbicide 1% Tenofovir Gel in the Prevention of Human Immunodeficiency Virus Type 1 Infection in Young Women, and to Examine Effects of the Microbicide on the Incidence of Herpes Simplex Virus Type 2 Infection.

Role: Laboratory Operations and Management, WHC CLS Chief Operations Officer: Dr Shiksha Gallow

  1. MTN 003 – USAID # IND#: 55,690    PI: Sinead Delany-Moretlwe    2009- 2014 

Phase 2B Safety and Effectiveness Study of Tenofovir 1% Gel, Tenofovir Disoproxil Fumarate Tablet and Emtricitabine/Tenofovir Disoproxil Fumarate Tablet for the Prevention of HIV Infection in Women

Role: Laboratory Operations and Management, CLS Chief Operations Officer.

  1. H3 Africa Biorepository    PI: Ute Jentsch    2014-2017

To monitor the storage conditions of medical samples for cancer research.    

Role: CO Principal Investigator, Wits health Consortium: Dr Shiksha Gallow

  1. LAB-ONQ-OPI-001    PI: Shiksha Gallow    2021-2023

 To investigate the replacement of Opioids with Medical Cannabis for Pain Management within the South African population.

Role: Principal Investigator: Dr Shiksha Gallow

  1. Cannabinoids inhibitory activity against SARS-COV-2 infection of cells.    2022- 2023

To design pcDNA3.1 plasmids encoding SARS-CoV-2 S proteins for different strains ▪ To produce SARS-CoV-2 pseudotyped viruses ▪ To determine the produced pseudotyped viruses’ infectivity ▪ To investigate cannabinoids inhibitory activity against SARS-CoV-2 entry into cells. ▪ Study of the cannabinoids’ cytotoxicity

Principal Investigators: Dr Alex Alexande and Dr Shiksha Gallow

  1. To investigate the chemical profile of South African landraces    2023-2025

Role: Co-Investigator

Principal Investigators: Professor David Katerere and Dr Shavhani

  1. To investigate the effect of cannabinoids on patients diagnosed with prostate cancer.    2021-2024                                       

Role: Principal Investigator (For PHD studies)